FISONS BV – Trademark Portfolio
Entity Type: 03
FISONS BV holds 38 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 32 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PENNKINETIC. The owner is based in 3833 AM LEUSDEN-C.
LARIKSLAAN 4
3833 AM LEUSDEN-C , NL
Showing of trademarks Trademarks
Trademark Classifications
FISONS BV's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does FISONS BV have?
FISONS BV has 38 U.S. trademarks filed with the USPTO. Of these, 1 registered, 14 abandoned, 23 cancelled.
What trademark classes does FISONS BV file in?
FISONS BV files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment), Class 1 (Chemicals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are FISONS BV's most well-known trademarks?
FISONS BV's registered trademark portfolio includes well-known marks such as PENNKINETIC. These are among 1 currently registered trademark in the portfolio.
What is FISONS BV's trademark registration success rate?
FISONS BV has a 3% trademark registration rate, with 1 out of 38 resolved applications resulting in successful registration. Currently, 0 applications are pending review.